MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, NTLA made $13,782,000 in revenue. -$100,987,000 in net income. Net profit margin of -732.75%.

Income Overview

Revenue
$13,782,000
Net Income
-$100,987,000
Net Profit Margin
-732.75%
EPS
-$0.92
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration revenue
13,782,000 14,245,000 16,627,000 16,255,333.333
Research and development
94,747,000 97,035,000 108,427,000 114,310,333.333
General and administrative
30,512,000 27,206,000 29,007,000 31,776,000
Total operating expenses
125,259,000 124,241,000 137,434,000 146,086,333.333
Operating loss
-111,477,000 -109,996,000 -120,807,000 -129,831,000
Interest income
6,714,000 7,402,000 8,603,000 11,895,000
Change in fair value of investments, net
3,439,000 1,339,000 -2,125,000 -9,833,666.667
Total other income, net
10,153,000 8,741,000 6,478,000 2,061,333.333
Net loss
-101,324,000 -101,255,000 -114,329,000 -127,769,666.667
Unrealized gain on marketable securities
337,000 -404,000 452,000 -1,240,333.333
Comprehensive loss
-100,987,000 -101,659,000 -113,877,000 -129,010,000
Net loss per share, basic
-0.92 -0.98 -1.1 -1.303
Net loss per share, diluted
-0.92 -0.98 -1.1 -1.303
Weighted average shares outstanding, basic
110,188,000 103,732,000 103,500,000 -717,666.667
Weighted average shares outstanding, diluted
110,188,000 103,732,000 103,500,000 -717,666.667
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$100,987,000 Unrealized gain onmarketable securities$337,000 Change in fair value ofinvestments, net$3,439,000 Interest income$6,714,000 Net loss-$101,324,000 Total other income,net$10,153,000 Operating loss-$111,477,000 Collaboration revenue$13,782,000 Total operatingexpenses$125,259,000 General andadministrative$30,512,000 Research and development$94,747,000

Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics, Inc. (NTLA)